Scaled Biolabs
Scaled Biolabs speeds up discovery and development of cell-based medicines by systematically mapping cellular responses across large experimental sets. It operates a Cell Therapy Discovery Engine that combines microfluidics, laboratory automation, and machine learning to screen hundreds of parameters across tens of thousands of experiments. The platform is offered as a discovery and development service and platform for biotech and pharmaceutical customers (B2B), and the company also advances internal cell therapy programs. Core technologies include microfluidic assay platforms, automated robotics, and ML-driven analytics to optimize cell products and processes. Scaled Biolabs targets the growing cell therapy market, aiming to shorten development timelines and improve manufacturability and clinical outcomes.
Scaled Biolabs
Scaled Biolabs speeds up discovery and development of cell-based medicines by systematically mapping cellular responses across large experimental sets. It operates a Cell Therapy Discovery Engine that combines microfluidics, laboratory automation, and machine learning to screen hundreds of parameters across tens of thousands of experiments. The platform is offered as a discovery and development service and platform for biotech and pharmaceutical customers (B2B), and the company also advances internal cell therapy programs. Core technologies include microfluidic assay platforms, automated robotics, and ML-driven analytics to optimize cell products and processes. Scaled Biolabs targets the growing cell therapy market, aiming to shorten development timelines and improve manufacturability and clinical outcomes.